MARINI, MARIA ADELAIDE
 Distribuzione geografica
Continente #
NA - Nord America 27.554
EU - Europa 1.955
AS - Asia 404
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
OC - Oceania 3
Totale 29.940
Nazione #
US - Stati Uniti d'America 27.546
DE - Germania 452
UA - Ucraina 416
CN - Cina 252
IE - Irlanda 226
IT - Italia 180
SE - Svezia 139
GB - Regno Unito 126
FR - Francia 111
FI - Finlandia 85
KR - Corea 83
RU - Federazione Russa 69
PL - Polonia 60
RO - Romania 34
BE - Belgio 20
JP - Giappone 11
KG - Kirghizistan 10
NL - Olanda 10
IN - India 9
BR - Brasile 7
CA - Canada 7
HK - Hong Kong 7
AT - Austria 6
ES - Italia 6
VN - Vietnam 6
SG - Singapore 5
CH - Svizzera 4
CL - Cile 4
EE - Estonia 4
EU - Europa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
ID - Indonesia 3
IL - Israele 3
TH - Thailandia 3
UZ - Uzbekistan 3
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
DM - Dominica 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
IQ - Iraq 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PK - Pakistan 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 29.940
Città #
Woodbridge 9.067
Wilmington 7.062
Houston 5.966
Fairfield 933
Ann Arbor 729
Chandler 491
Ashburn 480
Seattle 415
Jacksonville 373
Cambridge 328
Dublin 226
Dearborn 222
Medford 197
New York 147
Beijing 104
Lawrence 89
Rome 77
Mülheim 61
Kraków 58
Zhengzhou 52
Buffalo 50
San Diego 42
San Mateo 39
Menlo Park 37
Palo Alto 26
Falls Church 22
Detroit 21
Norwalk 21
Brussels 20
University Park 20
Milan 19
Boardman 17
Nanjing 17
Kunming 15
Saint Petersburg 15
Verona 15
Chicago 13
Mountain View 13
London 12
Hefei 11
Nürnberg 10
Phoenix 10
Shanghai 10
Indiana 8
Los Angeles 8
Redwood City 8
San Francisco 8
Center 6
Engelhard 6
Guangzhou 6
Auburn Hills 5
Dong Ket 5
Nanchang 5
Hong Kong 4
Naples 4
Seoul 4
Toronto 4
Changsha 3
Chengdu 3
Colorado Springs 3
Fuzhou 3
Gravina di Catania 3
Helsinki 3
Lanuvio 3
Paris 3
Pune 3
Redditch 3
Redmond 3
São Paulo 3
Tokyo 3
Aachen 2
Addis Ababa 2
Aldeno 2
Auckland 2
Bandung 2
Budapest 2
Chiswick 2
Cupertino 2
Edmonton 2
Fremont 2
Genoa 2
Hangzhou 2
Hounslow 2
Kemerovo 2
La Mancha 2
Milazzo 2
Novara 2
Nuremberg 2
Pantelimon 2
Pathum Thani 2
Reggio Calabria 2
Scandiano 2
Simi Valley 2
Wandsworth 2
Washington 2
Zeist 2
Acton 1
Almaty 1
Amsterdam 1
Anzio 1
Totale 27.728
Nome #
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 493
Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients 445
Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity 429
Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects 428
Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects 427
Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects 426
Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism 420
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 420
IL-18 gene polymorphism and metabolic syndrome 414
The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates 413
A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study 412
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels 408
Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects 407
Hydrolysis of leucine enkephalin and its association to the K562(S) erythroleukaemic cell line 403
Association of insulin resistance indexes to carotid intima-media thickness 403
Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein 402
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects 402
Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action 399
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 395
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance: the GISIR database 394
Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M 394
A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation 389
null 386
Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein 385
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 385
Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness 383
One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose 383
Insulin clearance is associated with carotid artery intima-media thickness 382
A rare cardiac finding in a morbidly obese patient with severe hypertension 381
Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies 379
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 379
Insulin sensitivity, and β-cell function in relation to hemoglobin A1C 377
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 372
Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes 372
Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding 370
Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies 370
Plasma interteukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians 369
The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients 366
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct 366
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 363
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes 362
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database 361
A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity 361
Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity 359
Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals 358
Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects 356
Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction 355
Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk 352
High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects 352
Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism 351
Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B 344
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals 344
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 342
Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells 341
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 340
Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels 338
Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis 338
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 334
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 332
Effect of differentiation on hydrolysis and association of Leu-enkephalin to K562(S) cells 330
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 321
Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels 320
Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients 319
Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance 319
Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase 318
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes 317
Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women 316
Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians 316
Inhibition of basal insulin secretion induces insulin resistance in normal man: evidence for a tonic effect of insulin on carbohydrate metabolism 314
Beta-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects 310
Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase 310
A polymorphism at IGF1 locus is associated with anemia 309
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity 306
Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria 304
Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding 299
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients 285
Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels 280
Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase 279
[Insulin secretion and insulin resistance in patients failing to respond to oral hypoglycemic agents] 263
Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells 254
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 254
Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue front NIDDM patients 253
[Preparation of 125I-labelled monoclonal antibodies of the insulin receptor] 238
Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia 110
The polymorphism rs35767 at IGF1 locus is associated with serum urate levels 93
Experimental evidence indicates that high‐density lipoprotein (HDL) may stimulate glucose uptake and improve β‐cell function. The aim of this study was to evaluate whether lower levels of HDL may affect the risk to develop type 2 diabetes. 80
One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes 51
HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: a longitudinal study 35
Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. 27
Low-density lipoprotein cholesterol levels are associated with first-phase insulin release 17
Response to Letter to the Editor: "One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes" 17
One-hour post-load glucose is associated with severity of hepatic fibrosis risk 14
Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance 11
Sex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes 10
Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance 9
Subcutaneous insulin infusion (CSII) in italy: The third national survey 7
Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance 5
Totale 30.131
Categoria #
all - tutte 52.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.923 0 0 0 0 0 0 0 0 0 0 991 932
2019/20207.823 676 760 532 693 696 848 748 701 613 639 427 490
2020/20214.095 446 473 425 570 360 370 507 390 131 103 223 97
2021/2022941 29 101 30 52 23 115 44 52 55 120 51 269
2022/20231.325 148 108 57 169 164 239 108 75 121 9 89 38
2023/2024422 53 15 43 6 50 175 28 29 7 11 5 0
Totale 30.131